Breadcrumb AMCP.org Resource Center AMCP submits comments to the Ohio Senate Health and Human Services Committee, opposing Sub. HB No. 505, a bill concerning biosimilars. Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page 3/18/19 AMCP submits comments to the Ohio Senate Health and Human Services Committee, opposing Sub. HB No. 505, a bill concerning biosimilars. MA Sub. H.B. No. 505.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page